Independent Study Finds Significant Benefits Provided by NanoVibronix's UroShield® Device

Stock Information for ENvue Medical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ENvue Medical Inc.

NanoVibronix Issues Letter to Shareholders
NanoVibronix Launches "Oscar" Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities
NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical's Intellectual Property Portfolio
NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology
NanoVibronix Announces Reverse Stock Split
NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock
NanoVibronix Announces ENvue Drive - First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.